Palladium(II) complexes of quinolinylaminophosphonates: Synthesis, structural characterization, antitumor and antimicrobial activity

Journal of Inorganic Biochemistry

Volumn 105, Issue 6, 2011, Pages 867-879

  Juribašić, Marina ^a   Molčanov, Krešimir ^a   Kojić Prodić, Biserka ^a   Bellotto, Lisa ^b   Kralj, Marijeta ^a   Zani, Franca ^c   Tušek Božić, Ljerka ^a  

^a RUDER BO KOVI INSTITUTE   (Croatia)

^b CNR Consiglio Nazionale delle Ricerche   (Italy)

^c UNIVERSITY OF PARMA   (Italy)

Author keywords

Antimicrobial activity; Antitumor activity; Crystal structure; Palladium(II) complex; Quinolinylaminophosphonate complex; Spectroscopy

Indexed keywords

ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; CIPROFLOXACIN; CISPLATIN; DIBUTYL[ALPHA ANILINO(QUINOLIN 2 YLMETHYL)]PHOSPHONATE DERIVATIVE; DIBUTYL[ALPHA ANILINO(QUINOLIN 3 YLMETHYL)]PHOSPHONATE DERIVATIVE; DIBUTYL[ALPHA(QUINOLIN 3 YLAMINO)N BENZYL]PHOSPHONATE DERIVATIVE; DIETHYL[ALPHA ANILINO(QUINOLIN 2 YLMETHYL)]PHOSPHONATE DERIVATIVE; DIETHYL[ALPHA ANILINO(QUINOLIN 3 YLMETHYL)]PHOSPHONATE DERIVATIVE; DIETHYL[ALPHA(QUINOLIN 3 YLAMINO)N BENZYL]PHOSPHONATE DERIVATIVE; MICONAZOLE; PALLADIUM COMPLEX; PHOSPHONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CHEMICAL BOND; CONCENTRATION RESPONSE; CRYSTAL STRUCTURE; DRUG STRUCTURE; DRUG SYNTHESIS; ELECTROSPRAY MASS SPECTROMETRY; HUMAN; HUMAN CELL; IC 50; INFRARED SPECTROSCOPY; NONHUMAN; PHOSPHORUS NUCLEAR MAGNETIC RESONANCE; PROTON NUCLEAR MAGNETIC RESONANCE; ULTRAVIOLET SPECTROSCOPY;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; HUMANS; LIGANDS; PALLADIUM; PHOSPHONIC ACIDS; QUINOLINES; SPECTROMETRY, MASS, ELECTROSPRAY IONIZATION;

BACTERIA (MICROORGANISMS); POSIBACTERIA;

EID: 79955098805     PISSN: 01620134     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinorgbio.2011.03.011     Document Type: Article

References (65)

1. Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug, in: B. Lippert (Ed.), Wiley-VCH, Weinheim, 1999.
2. P.J. O'Dwyer, P. Stevenson, S.W. Johnson, Clinical status of cisplatin, carboplatin, and other platinum-based antitumor drugs, in: B. Lippert (Ed.), Cisplatin: Chemistry and Biochemistry of a Leading Anticancer Drug, Verlag Helvetica Chimica Acta, Zurich, 1999, pp. 31-72.
3. G. Natile, M. Coluccia, Coord. Chem. Rev. 216-217 (2001) 383-410.
4. G. Momekov, A. Bakalova, M. Karaivanova, Curr. Med. Chem. 12 (2005) 2177-2191.
5. S. van Zutphen, J. Reedijk, Coord. Chem. Rev. 249 (2005) 2845-2853.
6. J. Reedijk, Eur. J. Inorg. Chem. (2009) 1301-13128 and references therein.
7. S.M. Aris, N.P. Farrell, Eur. J. Inorg. Chem. (2009) 1293-1302.
8. E. Alessio, G. Menstroni, A. Bergamo, G. Sava, Curr. Top. Med. Chem. 4 (2004) 1525-1535.
9. G. Zhao, H. Lin, Curr. Med. Chem. Anticancer Agents 5 (2005) 137-147.
10. M.A. Jakupec, M. Galanski, V.B. Arion, C.G. Hartinger, B.K. Kepler, Dalton Trans. (2008) 183-194.
11. A. Alama, B. Tasso, F. Novelli, F. Sparatore, Drug Discov. Today 14 (2009) 500-508.
12. A. Casini, C. Hartinger, C. Gabbiani, E. Mini, P.J. Dyson, B.K. Keppler, L. Messori, J. Inorg. Biochem. 102 (2008) 564-575.
13. P. Kafarski, B. Lejczak, Aminophosphonic and aminophosphinic acids, in: V.P. Kukhar, H.R. Hudson (Eds.), Chemistry and Biological Activity, John Wiley & Sons, Chichester, 2000, pp. 407-442.
14. H. Kozlowski, A. Pusino, J. Swiatek, J. Spychala, T. Glowiak, G. Micera, C. Gessa, J. Agric, Food Chem. 38 (1990) 1989-1992.
15. P. Kafarski, B. Lejczak, Curr. Med. Chem. Anticancer Agents 1 (2001) 301-312.
16. T. Klenner, P. Valenzuela-Paz, F. Amelung, H. Münch, H. Zahn, B.K. Keppler, H. Blum, Platinum phosphonato complexes with particular activity against bone malignancies. An evaluation of an experimental model highly predictive for the clinical situation, in: B.K. Keppler (Ed.), Metal Complexes in Cancer Chemotherapy, VCH, Weinheim, 1993, pp. 85-127.
17. Lj. Tušek-Božić, I. Matijašić, G. Bocelli, G. Calestani, A. Furlani, V. Scarcia, A. Papaioannou, J. Chem. Soc. Dalton. Trans. (1991) 195-201.
18. Lj. Tušek-Božić, I. Matijašić, G. Bocelli, G. Sgarabotto, A. Furlani, V. Scarcia, A. Papaioannou, Inorg. Chim. Acta 185 (1991) 229-237.
19. Lj. Tušek-Božić, A. Furlani, V. Scarcia, E. De Clercq, J. Balzarini, J. Inorg. Biochem. 72 (1998) 201-210.
20. Lj. Tušek-Božić, F. Frausin, V. Scarcia, A. Furlani, J. Inorg. Biochem. 95 (2003) 259-269.
21. Lj. Tušek-Božić, M. Juribašić, P. Traldi, V. Scarcia, A. Furlani, Polyhedron 27 (2008) 1317-1328.
22. M. Ćurić, Lj. Tušek-Božić, D. Vikić-Topić, V. Scarcia, A. Furlani, J. Balzarini, E. De Clercq, J. Inorg. Biochem. 63 (1996) 125-142.
23. Lj. Tušek-Božić, M. Komac, M. Ćurić, A. Lyčka, M. D'Alpaos, V. Scarcia, A. Furlani, Polyhedron 19 (2000) 937-948.
24. Lj. Tušek-Božić, V. Cmrečki, J. Balzarini, E. De Clercq, Lett. Drug Des. Discov. 3 (2006) 528-533.
25. E. Budzisz, U. Krajewska, M. Rozalski, A. Szulawska, M. Czyz, B. Nawrot, Eur. J. Pharmacol. 502 (2004) 59-65.
26. J. Kuduk-Jaworska, A. Puszko, M. Kibiak, M. Pelczynska, J. Inorg. Biochem. 98 (2004) 1447-1456.
27. D. Kovala-Demertzi, A. Bocarelli, M.A. Demertzis, M. Coluccia, Chemotherapy 53 (2007) 148-152.
28. G. Faraglia, D. Fregona, S. Sitran, L. Giovagnini, C. Marzano, F. Baccichetti, U. Casellato, R. Graziani, J. Inorg. Biochem. 83 (2001) 31-40.
29. L. Giovagnini, L. Ronconi, D. Aldinucci, D. Lorenzon, S. Sitran, D. Fregona, J. Med. Chem. 48 (2005) 1588-1595.
30. A. Garoufis, S.K. Hadjikakou, N. Hadjiliadis, Coord. Chem. Rev. 253 (2009) 1384-13978 and references therein.
31. S. Kumar, S. Bawa, H. Gupta, Mini Reviews Med. Chem. 9 (2009) 1648-1654.
32. F. O'Donnell, T.J.P. Smyth, V.N. Ramachandran, W.F. Smyth, Int. J. Antimicrob. Agents 35 (2010) 30-38.
33. A.H. Kategaonkar, R.U. Pokalwar, S.S. Sonar, V.U. Gawali, B.B. Shingate, M.S. Shingare, Eur. J. Med. Chem. 45 (2010) 1128-1132.
34. Lj. Tušek-Božić, M. Juribašić, M. Komac, V. Cmrečki, I. Zrinski, J. Balzarini, E. De Clercq, Lett. Org. Chem. 4 (2007) 332-338.
35. M. Juribašić, L. Stella, Ž. Marinić, M. Vinković, Lj. Tušek-Božić, Lett. Org. Chem. 6 (2009) 11-16.
36. M.J.A. Jungbauer, C. Curran, Spectrochim. Acta 21 (1965) 641-648.
37. A.K. Majumdar, S.P. Bag, Frasenius Zeit. Analyt. Chem. 165 (1959) 247-250.
38. CrysAlis PRO, Oxford Diffraction Ltd, Oxford, U. K, 2007.
39. G.M. Sheldrick, Acta Crystallogr. A64 (2008) 112-122.
40. A.L. Spek, J. Appl. Crystallogr. 36 (2003) 7-13.
41. L.J. Farrugia, J. Appl. Crystallogr. 30 (1997) 565-566.
42. P. McCabe, E. Pidcock, G.P. Shields, R. Taylor, M. Towler, C.F. Macrae, P.R. Edgington, J. Van de Streek, J. Appl. Crystallogr. 39 (2006) 453-457.
43. M.R. Boyd, K.D. Pauli, Drug Dev. Res. 34 (1995) 91-109.
44. T. Mossman, Immunol. Meth. 65 (1983) 55-63.
45. J.H. Jorgensen, J.D. Turnidge, in: P.R. Murray, E.J. Baron, M.A. Pfaller, F.C. Tenover, R.H. Yolken (Eds.), Manual of Clinical Microbiology, American Society for Microbiology, Washington, DC, 1999, pp. 1526-1554 and 1640-1652.
46. Z. Ružić-Toroš, B. Kojić-Prodić, M. Šljukić, Acta Crystallogr. B34 (1978) 3110-3113.
47. C. Li, B. Song, K. Yan, G. Xu, D. Hu, S. Yang, L. Jin, W. Xue, P. Lu, Molecules 12 (2007) 163-1728 and references therein.
48. V. Diez, J.V. Cuevas, G. Garcia-Herbosa, G. Aullon, J.P.H. Charmant, A. Carbayo, A. Munoz, Inorg. Chem. 46 (2007) 568-578.
49. S. Doherty, J.G. Knight, T.H. Scanian, M.R.J. Elsegood, W. Clegg, J. Organomet. Chem. 650 (2002) 231-248.
50. V. Terrasson, D. Prim, J. Marrot, Eur. J. Inorg. Chem. (2008) 2739-2745.
51. C.-Y. Liao, K.-T. Chan, C.-Y. Tu, Y.-W. Chang, C.-H. Hu, H.M. Lee, Chem. Eur. J. 15 (2009) 405-417.
52. J. Bernstein, R.E. Davis, L. Shimoni, N.-L. Chang, Angew. Chem. Int. Ed. 34 (1995) 1555-1573.
53. A.L. Spek, private commun, 2000.
54. U. Kalinowska, L. Chȩcińska, M. Małecka, A. Erxleben, B. Lippert, J. Ochocki, Inorg. Chim. Acta 358 (2005) 2464-2472.
55. L.C. Thomas, Interpretation of Infrared Spectra of Organophosphorus Compounds, Plenum Press, New York, 1974.
56. M. Juribašić, Lj. Tušek-Božić, J. Mol. Struct. 924-926 (2009) 66-72.
57. K. Nakamoto, Infrared and Raman Spectra of Inorganic and Coordination Compounds, Part B: Applications in Coordination Organometallic and Bioinorganic Chemistry, 5th Ed, Wiley-Interscience, 1997.
58. Lj. Tušek-Božić, M. D'Alpaos, Polyhedron 17 (1998) 1481-1493.
59. A. Albinati, P.S. Pregosin, F. Wombacher, Inorg. Chem. 29 (1990) 1812-1817.
60. Lj. Tušek-Božić, M. Ćurić, D. Vikić-Topić, A. Lyčka, Collect. Czech. Chem. Commun. 62 (1997) 1888-1904.
61. L.A. Silks III, J. Peng, J.D. Odom, B. Dunlap, J. Org. Chem. 56 (1991) 6733-6736.
62. H.H. Jaffe, M. Orchin, Theory and Applications of Ultraviolet Spectroscopy, J. Wiley, New York, 1962.
63. S.E. Livingstone, The Chemistry of Ruthenium, Rhodium, Palladium, Osmium, Iridium and Platinum Complexes, Pergamon Press, Oxford, 1973.
64. J.P. Souchard, T.T.B. Ha, S. Cros, N.P. Johnson, J. Med. Chem. 34 (1991) 863-864.
65. S. Fakih, W.C. Tung, D. Eierhoff, C. Mock, B. Krebs, Z. Anorg. Allg. Chem. 631 (2005) 1397-1402.